PortfoliosLab logoPortfoliosLab logo
PBE vs. ICLN
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

PBE vs. ICLN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco Dynamic Biotechnology & Genome ETF (PBE) and iShares Global Clean Energy ETF (ICLN). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PBE achieves a 3.32% return, which is significantly lower than ICLN's 28.34% return. Over the past 10 years, PBE has underperformed ICLN with an annualized return of 8.90%, while ICLN has yielded a comparatively higher 11.52% annualized return.


PBE

1D
0.81%
1M
4.85%
YTD
3.32%
6M
5.17%
1Y
34.13%
3Y*
10.91%
5Y*
2.31%
10Y*
8.90%

ICLN

1D
0.80%
1M
-3.23%
YTD
28.34%
6M
28.17%
1Y
61.48%
3Y*
5.46%
5Y*
-0.17%
10Y*
11.52%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PBE vs. ICLN - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
PBE
Invesco Dynamic Biotechnology & Genome ETF
3.32%24.84%1.10%3.71%-10.83%1.54%25.66%18.65%-0.19%22.28%
ICLN
iShares Global Clean Energy ETF
28.34%47.05%-25.72%-20.41%-5.43%-24.18%141.82%44.36%-9.03%21.47%

Correlation

The correlation between PBE and ICLN is 0.32, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.32

Correlation (3Y)
Calculated over the trailing 3-year period

0.42

Correlation (5Y)
Calculated over the trailing 5-year period

0.50

Correlation (10Y)
Calculated over the trailing 10-year period

0.49

Correlation (All Time)
Calculated using the full available price history since Jun 25, 2008

0.50

The correlation between PBE and ICLN shifts across timeframes, from 0.32 (1 year) to 0.50 (all time), reflecting how their relationship changes across market environments.

PBE vs. ICLN - Sectors Allocation Comparison


Sectors
PBE
ICLN

Healthcare

99.9%

-

Financial Services

0.2%

-

Basic Materials

-

1.3%

Communication Services

-

-

Consumer Cyclical

-

0.1%

Consumer Defensive

-

-

Energy

-

24.9%

Industrials

-

26.2%

Real Estate

-

-

Technology

-

10.8%

Utilities

-

35.4%

Healthcare

PBE
99.9%
ICLN

-

Financial Services

PBE
0.2%
ICLN

-

Basic Materials

PBE

-

ICLN
1.3%

Communication Services

PBE

-

ICLN

-

Consumer Cyclical

PBE

-

ICLN
0.1%

Consumer Defensive

PBE

-

ICLN

-

Energy

PBE

-

ICLN
24.9%

Industrials

PBE

-

ICLN
26.2%

Real Estate

PBE

-

ICLN

-

Technology

PBE

-

ICLN
10.8%

Utilities

PBE

-

ICLN
35.4%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PBE vs. ICLN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PBE
PBE Risk / Return Rank: 5858
Overall Rank
PBE Sharpe Ratio Rank: 5858
Sharpe Ratio Rank
PBE Sortino Ratio Rank: 6363
Sortino Ratio Rank
PBE Omega Ratio Rank: 5353
Omega Ratio Rank
PBE Calmar Ratio Rank: 6363
Calmar Ratio Rank
PBE Martin Ratio Rank: 5252
Martin Ratio Rank

ICLN
ICLN Risk / Return Rank: 7373
Overall Rank
ICLN Sharpe Ratio Rank: 7777
Sharpe Ratio Rank
ICLN Sortino Ratio Rank: 6767
Sortino Ratio Rank
ICLN Omega Ratio Rank: 6464
Omega Ratio Rank
ICLN Calmar Ratio Rank: 8080
Calmar Ratio Rank
ICLN Martin Ratio Rank: 7979
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PBE vs. ICLN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Biotechnology & Genome ETF (PBE) and iShares Global Clean Energy ETF (ICLN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PBEICLNDifference
Sharpe ratioReturn per unit of total volatility

-0.38

Sortino ratioReturn per unit of downside risk

-0.07

Omega ratioGain probability vs. loss probability

1.31

1.35

-0.04

Calmar ratioReturn relative to maximum drawdown

2.92

3.77

-0.85

Martin ratioReturn relative to average drawdown

8.21

13.82

-5.61

PBE vs. ICLN - Sharpe Ratio Comparison

The current PBE Sharpe Ratio is 1.81, which is comparable to the ICLN Sharpe Ratio of 2.19. The chart below compares the historical Sharpe Ratios of PBE and ICLN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

PBE vs. ICLN - Drawdown Comparison

The maximum PBE drawdown since its inception was -45.69%, smaller than the maximum ICLN drawdown of -87.15%. Use the drawdown chart below to compare losses from any high point for PBE and ICLN.


Loading charts...

Drawdown Indicators


PBEICLNDifference

Max Drawdown

Largest peak-to-trough decline

-45.69%

-87.15%

+41.46%

Max Drawdown (1Y)

Largest decline over 1 year

-11.73%

-16.38%

+4.65%

Max Drawdown (3Y)

Largest decline over 3 years

-22.43%

-43.18%

+20.75%

Max Drawdown (5Y)

Largest decline over 5 years

-34.71%

-57.16%

+22.45%

Max Drawdown (10Y)

Largest decline over 10 years

-37.84%

-66.75%

+28.91%

Current Drawdown

Current decline from peak

-1.00%

-42.58%

+41.58%

Average Drawdown

Average peak-to-trough decline

-16.21%

-66.55%

+50.34%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.17%

4.46%

-0.29%

Volatility

PBE vs. ICLN - Volatility Comparison

The current volatility for Invesco Dynamic Biotechnology & Genome ETF (PBE) is 6.04%, while iShares Global Clean Energy ETF (ICLN) has a volatility of 12.94%. This indicates that PBE experiences smaller price fluctuations and is considered to be less risky than ICLN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PBEICLNDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.04%

12.94%

-6.90%

Volatility (6M)

Calculated over the trailing 6-month period

13.67%

22.57%

-8.90%

Volatility (1Y)

Calculated over the trailing 1-year period

19.01%

28.28%

-9.27%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

22.48%

27.55%

-5.07%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

24.91%

27.33%

-2.42%

PBE vs. ICLN - Expense Ratio Comparison

PBE has a 0.59% expense ratio, which is higher than ICLN's 0.39% expense ratio.


Dividends

PBE vs. ICLN - Dividend Comparison

PBE's dividend yield for the trailing twelve months is around 1.02%, less than ICLN's 1.54% yield.


PositionTTM20252024202320222021202020192018201720162015
ICLN
iShares Global Clean Energy ETF
1.54%1.63%1.85%1.59%0.89%1.18%0.34%1.36%2.77%2.49%3.88%2.36%
PBE
Invesco Dynamic Biotechnology & Genome ETF
1.02%1.00%0.05%0.02%0.00%0.00%0.04%0.00%0.00%0.57%0.38%1.12%

Frequently Asked Questions


PBE and ICLN have a correlation of 0.32, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ICLN has higher volatility (12.94%) compared to PBE (6.04%). In terms of maximum drawdown, PBE dropped -45.69% vs ICLN's -87.15%.

On 10-year performance, ICLN leads with 11.52% vs 8.90% for PBE. On fees, ICLN is cheaper at 0.39% per year. On volatility, PBE has been the lower-risk option at 6.04%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, ICLN has performed better with a 11.52% return vs 8.90%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

ICLN is cheaper with a 0.39% expense ratio, compared with 0.59% for PBE.

ICLN has the higher dividend yield at 1.54%, compared with 1.02% for PBE.

PBE is categorized as Health & Biotech Equities, while ICLN is Alternative Energy Equities. PBE tracks Dynamic Biotech & Genome Intellidex Index (AMEX), while ICLN tracks S&P Global Clean Energy Index. They also come from different issuers: Invesco and iShares. Their fees differ too: 0.59% for PBE and 0.39% for ICLN.

ICLN currently has the higher Sharpe Ratio (2.19 vs 1.81), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PBE and ICLN

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer